Tag: Jack Bailey
G1 Therapeutics’ Phase 3 trial of trilaciclib for metastatic triple negative breast cancer continues as planned
In a significant update for the oncology community, G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage company specializing in cancer treatment, announced the continuation of its ... Read More
G1 Therapeutics gets Cosela FDA approval to reduce chemotherapy-induced bone marrow suppression
G1 Therapeutics has bagged approval for Cosela (trilaciclib) from the US Food and Drug Administration (FDA) for reducing bone marrow suppression caused by chemotherapy. Cosela ... Read More
Priority Power Management acquires Texas Power Consultants
Priority Power Management, an energy management services and consulting firm, has acquired Texas Power Consultants (TPC) for an undisclosed price. Based in Tyler, Texas Power ... Read More